前列地尔应用于肺动脉高压治疗的临床效果观察与评价郭维摘要：目的：观察前

Alprostadil applied to the clinical treatment of pulmonary hypertension and Efficacy Evaluation <br>Guo <br>Abstract: Objective: To observe the effects of alprostadil applied pulmonary arterial hypertension (PAH) therapy. <br>Method: In 72 patients with PAH hospital treated randomly divided into experimental groups (n = 36) and control group (n = 36). <br>The control group received routine treatment, the experimental group received intravenous infusion of alprostadil on the basis of the control group. <br>Comparison of the two groups of patients clinically relevant indicators and adverse reactions. <br>Results: After the treatment, patients were Borg score and pulmonary artery systolic pressure levels decreased arterial oxygen partial pressure level rises, the index and the degree of change in the experimental group than the control group (P18 years. <br>Exclusion criteria: ① pulmonary valve along with the right or ventricular outflow tract obstruction, right atrioventricular valve disease and so on. <br>② there are contraindications or allergy to alprostadil. <br>③ with liver, kidney and other organ systems or major blood diseases, immune and other. <br>④ with cognitive, mental or communication barriers disease <br>after patients were enrolled given oxygen, bed rest, ECG and other conventional treatment, to cardiac, diuretic, and other related anticoagulation therapy under doctor's orders.

Clinical effect observation and evaluation applied to pulmonary hypertension therapy of protothel<br>Guo Wei<br>Abstract: Objective: To observe the effect of protomide arter's application in the treatment of pulmonary arterial hypertension (PAH).<br>Methods: 72 PAH patients treated in our hospital were randomly divided into experimental group (n-36) and control group (n-36).<br>The control group was given routine treatment, and the experimental group gave the forefront of the intravenous drip on the basis of the control group.<br>The clinically relevant indicators and adverse reactions of two groups were compared.<br>Results: After treatment, the patients in the two groups of Borg had difficulty breathing score and pulmonary arterial systolic pressure decreased, the level of arterial blood oxygen score increased, and the above-mentioned index change was greater than that of the control group (P18 years).<br>Exclusion criteria: (1) accompanied by pulmonary valve or right chamber outflow path stenosis, right room valve lesions, etc.<br>(2) There are contraindications or allergies to the forefront.<br>(3) Combined liver, kidney and other organs or blood, immune and other major diseases.<br>(4) Have cognitive, communication or mental illness.<br>Both groups of patients were given oxygen absorption, bed rest, electrocardiogram and other conventional treatment, according to medical advice to strong heart, diuretic, anticoagulant and other related treatment.

Clinical observation and evaluation of prostaglandin in the treatment of pulmonary hypertension<br>Guo Wei<br>Abstract: Objective: To observe the effect of alprostadil in the treatment of pulmonary hypertension (PAH).<br>Methods: 72 patients with PAH were randomly divided into experimental group (n = 36) and control group (n = 36).<br>The control group was given routine treatment, and the experimental group was given alprostadil intravenous drip on the basis of the control group.<br>The clinical indexes and adverse reactions were compared between the two groups.<br>Results: after treatment, Borg dyspnea score and pulmonary systolic blood pressure decreased, while arterial oxygen pressure increased in the two groups, and the changes of the above indexes in the experimental group were greater than those in the control group (P18 years old).<br>Exclusion criteria: ① with pulmonary valve or right ventricular outflow tract stenosis, right atrioventricular valve lesions, etc.<br>② There are contraindications or allergies to alprostadil.<br>③ Combined with liver, kidney and other organs or blood, immune system and other major diseases.<br>④ Have cognitive, communication or mental disorders.<br>After entering the group, the patients in the two groups were given routine treatment such as oxygen inhalation, bed rest, electrocardiographic monitoring, and other related treatment such as cardiotonic, diuretic, anticoagulation, etc.<br>